However, a previous study conducted in 295 patients with T2DM reported that their serum 25-hydroxy vitamin D3 levels were significantly higher in patients treated with DPP-4 inhibitors than those treated with other antihyperglycemic mediations [28]. This evidence concerns the gene DPP4 and type 2 diabetes mellitus.